Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
  1. 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 670 shares (to pay taxes)
  2. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 1,371 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Accounting Officer gave up 245 shares (to pay taxes)
  4. 4 Shares withheld for taxes EVP, Human Resources gave up 634 shares (to pay taxes)
  5. 4 Shares withheld for taxes EVP Chief Legal Officer gave up 807 shares (to pay taxes)
  6. 4 Shares withheld for taxes Head of Global Product Strat. gave up 445 shares (to pay taxes)
  7. 4 Shares withheld for taxes Head of Global Product Strat. gave up 1,165 shares (to pay taxes)
  8. 4 Shares withheld for taxes EVP, Chief Financial Officer gave up 1,502 shares (to pay taxes)
  9. 4 Shares withheld for taxes President and CEO gave up 3,201 shares (to pay taxes)
  10. 4 Shares withheld for taxes Head of Research gave up 443 shares (to pay taxes)
  11. 4 Shares withheld for taxes Head of Corporate Development gave up 563 shares (to pay taxes)
  12. 4 Derivatives Options or other derivatives
  13. 4 Shares withheld for taxes Chief Accounting Officer gave up 476 shares (to pay taxes)
  14. 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 1,223 shares (to pay taxes)
  15. 4 Shares withheld for taxes Head of Development gave up 681 shares (to pay taxes)
  16. 4 Shares withheld for taxes EVP, Human Resources gave up 1,040 shares (to pay taxes)
  17. 4 Shares withheld for taxes EVP Chief Legal Officer gave up 1,234 shares (to pay taxes)
  18. 4 Shares withheld for taxes Head of Development gave up 578 shares (to pay taxes)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Planned sale Head of Development sold 110 shares at $157.21 ($17,293)

Page 4 of 86 · 1,714 filings